Cargando…

Reduction in murine acute GVHD severity by human gingival tissue-derived mesenchymal stem cells via the CD39 pathways

Human gingival tissue-derived mesenchymal stem cells (GMSCs) present an accessible source of mesenchymal stem cells (MSCs) for treating autoimmune diseases. Here we show that human GMSCs can prevent and treat acute graft-versus-host disease (GVHD) in two different mouse models. Our results indicate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ni, Xuhao, Xia, Yongxiang, Zhou, Shun, Peng, Hao, Wu, Xiao, Lu, Hao, Wang, Han, Liu, Rui, Blazar, Bruce R., Gu, Jian, Lu, Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325106/ https://www.ncbi.nlm.nih.gov/pubmed/30622237 http://dx.doi.org/10.1038/s41419-018-1273-7

Ejemplares similares

Inflammasome effects in GvHD
por: Koehn, Brent H., et al.
Publicado: (2015)

Human CD39(hi) regulatory T cells present stronger stability and function under inflammatory conditions
por: Gu, Jian, et al.
Publicado: (2017)

Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality
por: Holtan, Shernan G., et al.
Publicado: (2023)

Mesenchymal stem cell as salvage treatment for refractory chronic GVHD
por: Weng, J Y, et al.
Publicado: (2010)

Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD
por: Buxbaum, Nataliya P., et al.
Publicado: (2022)

High incidence of thromboembolism in patients with chronic GVHD: association with severity of GVHD and donor-recipient ABO blood group
por: El Jurdi, Najla, et al.
Publicado: (2021)

Third-party type 2 innate lymphoid cells prevent and treat GI tract GvHD
por: Bruce, Danny W., et al.
Publicado: (2021)

Rapamycin Regulates iTreg Function through CD39 and Runx1 Pathways
por: Lu, Yunjie, et al.
Publicado: (2014)

CD39 molecule: a negative regulator expressed on T cells in patients with lung adenocarcinoma
por: Tang, Lu, et al.
Publicado: (2023)

Topical Tacrolimus and Periodontal Therapy in the Management of a Case of Oral Chronic GVHD Characterized by Specific Gingival Localization
por: Conrotto, Davide, et al.
Publicado: (2014)

Tyrosine supplement ameliorates murine aGVHD by modulation of gut microbiome and metabolome
por: Li, Xiaoqing, et al.
Publicado: (2020)

Therapeutic Potential of a Senolytic Approach in a Murine Model of Chronic GVHD
por: Raman, Deepika, et al.
Publicado: (2023)

Human gingival tissue-derived MSC suppress osteoclastogenesis and bone erosion via CD39-adenosine signal pathway in autoimmune arthritis
por: Luo, Yang, et al.
Publicado: (2019)

Identification of CD3(+)CD4(-)CD8(-)T cells as potential regulatory cells in an experimental murine model of graft vs. host skin disease (GvHD)
por: Miyagawa, Fumi, et al.
Publicado: (2013)

GVHD-derived plasma as a priming strategy of mesenchymal stem cells
por: Silva-Carvalho, Amandda Évelin, et al.
Publicado: (2020)

Efficient treatment of murine acute GvHD by in vitro expanded donor regulatory T cells
por: Riegel, Christin, et al.
Publicado: (2019)

GVHD Prophylaxis 2020
por: Gooptu, Mahasweta, et al.
Publicado: (2021)

Adoptive Transfer of Treg Cells Combined with Mesenchymal Stem Cells Facilitates Repopulation of Endogenous Treg Cells in a Murine Acute GVHD Model
por: Lee, Eun-Sol, et al.
Publicado: (2015)

Impaired thymic iNKT cell differentiation at early precursor stage in murine haploidentical bone marrow transplantation with GvHD
por: Zhao, Weijia, et al.
Publicado: (2023)

CD39 deficiency in murine liver allografts promotes inflammatory injury and immune-mediated rejection
por: Yoshida, Osamu, et al.
Publicado: (2015)

SUV39H1 Reduction Is Implicated in Abnormal Inflammation in COPD
por: Chen, Tzu-Tao, et al.
Publicado: (2017)

Rearrangement of T Cell genome architecture regulates GVHD
por: Sun, Yaping, et al.
Publicado: (2022)

Gingival mesenchymal stem cells
por: Venkatesh, Deepak, et al.
Publicado: (2017)

Review immune response of targeting CD39 in cancer
por: Liu, Yao, et al.
Publicado: (2023)

Donor bone marrow–derived macrophage MHC II drives neuroinflammation and altered behavior during chronic GVHD in mice
por: Adams, Rachael C., et al.
Publicado: (2022)

Il-6 is non-essential to murine CD19 CAR efficacy, but can mediate acute GVHD following allogeneic BMT with CAR T cell infusion
por: Jacoby, Elad, et al.
Publicado: (2015)

Evaluation of IL-23p19/Ebi3 (IL-39) gingival crevicular fluid levels in periodontal health, gingivitis, and periodontitis
por: Sari, Aysegul, et al.
Publicado: (2022)

Targeting Cytokines in GVHD Therapy
por: Kumar, Sandeep, et al.
Publicado: (2017)

Editorial: Interferons and GvHD
por: Kim, Boram, et al.
Publicado: (2022)

Regulatory T Cells in GVHD Therapy
por: Guo, Wen-wen, et al.
Publicado: (2021)

Milestones in acute GVHD pathophysiology
por: Socie, Gerard, et al.
Publicado: (2022)

Helios, CD73 and CD39 Induction in Regulatory T Cells Exposed to Adipose Derived Mesenchymal Stem Cells
por: Fakhimi, Maryam, et al.
Publicado: (2020)

Corrigendum: SUV39H1 Reduction Is Implicated in Abnormal Inflammation in COPD
por: Chen, Tzu-Tao, et al.
Publicado: (2017)

Utility of eGVHD App for bedside GVHD assessment in a high-volume BMT center
por: Chhabra, Prashant, et al.
Publicado: (2023)

Posttransplant cyclophosphamide vs tacrolimus–based GVHD prophylaxis: lower incidence of relapse and chronic GVHD
por: Maurer, Katie, et al.
Publicado: (2023)

Chronic GVHD after steroid-sensitive, -dependent, and -refractory acute GVHD: incidence and clinical outcomes
por: Herzog, Shannon, et al.
Publicado: (2023)

Metabolic Reprogramming of GMP Grade Cord Tissue Derived Mesenchymal Stem Cells Enhances Their Suppressive Potential in GVHD
por: Mendt, Mayela, et al.
Publicado: (2021)

CD39/CD73/A2AR pathway and cancer immunotherapy
por: Xia, Chenglai, et al.
Publicado: (2023)

Evidence for CD19B–CD8T cell interactions in blood and tissues from patients with GvHD
por: Deola, S, et al.
Publicado: (2017)

Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD
por: Hildebrandt, G C, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_89iuf8gmu4c5qb7o73fc7iogq8